Soft Cell

California offically launched its controversial $3 billion stem cell research program. Robert Klien, the chairman of the operation, went on record pledging “public oversight, transparency, accountability and the highest ethical conduct” for the committee. After the news conference, calls for Klien’s resignation were put forward by the Bush administration.